New strategies for inhibiting tumor angiogenesis

Collaborations

• Krombach F, Institute for Surgical Research, University of Munich, Munich, Germany
• Liebner S, Institute of Neurology, Medical School, University of Frankfurt/Main, Germany
• Mantovani A, Istituto Clinico Humanitas, Milan, Italy
• Weber C, From the Department of Molecular Cardiovascular Research, RWTH University Hospital, Aachen, Germany
• Bos JL, Department of Physiological Chemistry and Centre for Biochemical Genetics, University Medical Centre, Utrecht, The Netherlands
• Wrana JL, Centre for System Biology, Mount Sinai Hospital, Toronto, Canada
• Letarte M, Cancer Research Program, Hospital for Sick Children and the Heart and Stroke Lewar Center of Excellence and Department of Immunology, University of Toronto, Canada
• Latini R, Mario Negri Institute for Pharmacological Research, Milan, Italy
• Dimmeler S, Molecular Cardiology, Department of Internal Medicine III, University of Frankfurt, Frankfurt/Main, Germany
• Koopman P, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia
• McDonald D, Department of Anatomy and Cardiovascular Research Institute, University of California, San Francisco
• Alitalo K, Molecular/Cancer Biology Laboratory, Biomedicum, Helsinki, Finland
• Carmeliet P, Center for Transgene Technology and Gene Therapy, Flanders and Interuniversity Institute for Biotechnology, University of Leuven, Leuven, Belgium
• Nourshargh S and Anna Randi, Cardiovascular Medicine Unit, National Heart and Lung Institute, Imperial College London, London, United Kingdom
• Pardi R, Unit of Leukocyte Biology, Vita-Salute San Raffaele University School of Medicine, DIBIT-Scientific Institute San Raffaele, Milan, Italy
• Cossu G, Stem Cell Research Institute, San Raffaele Scientific Institute, Milan, Italy
• Drake C, Department of Cell Biology and The Cardiovascular Developmental Biology Center, Charleston, South Carolina; the National Cancer Institute